June 25, 2026 Type 1 diabetes briefing: trials, device safety, and research signals
A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.
The short version
The June 25, 2026 feed is strongest in three lanes: device safety, recruiting studies, and recent research records. Type1Cure treats safety and trial records as higher-priority signals because they can affect what a family may need to check, ask, or watch next.
This is not a medical recommendation. It is a source map and plain-English triage layer designed to help families decide what deserves a closer look with their care team.
Signals in the feed
- A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — RECRUITING, PHASE3. Interventions: Baricitinib, Placebo. Locations: Tallahassee, Florida, United States | Tampa, Florida, United States | Iowa City, Iowa, United States. The purpose of this study is to find out if baric...Source
- Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery — RECRUITING, NA. Interventions: Bionic Pancreas, Routine Care. Locations: Aurora, Colorado, United States | Boston, Massachusetts, United States. The goal of this randomized controlled trial is to compare the efficacy an...Source
- Regulation of Brain Glucose Metabolism in Type 1 Diabetes — RECRUITING, EARLY_PHASE1. Interventions: Dichloroacetate. Locations: New Haven, Connecticut, United States. This is a prospective randomized placebo-controlled double-blind crossover pilot study determining the effect o...Source
- Type 1 Diabetes REst for Metabolic Health — RECRUITING, NA. Interventions: Sleep Health and Circadian Timing Intervention. Locations: Aurora, Colorado, United States. Research has shown a link between poor sleep health and late circadian timing with cardiometabol...Source
- Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App Model/Catalog Number: SW12300 Software Version: Versions 2.9.0 through 2.11.2 Produc... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...Source
- Dexcom, Inc.: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App Model/Catalog Number: SW13355 Software Version: Versions 2.9.0 through 2.11.2 Pr... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...Source
- Dexcom, Inc.: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App Model/Catalog Number: SW14244 Software Version: versions 1.5.0 and 1.6.0 Product... — A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV noti...Source
How to use this briefing
Start with the evidence label. Official registry and regulator records are not the same thing as advice, but they are stronger source material than a repost, rumor, or promotional headline.
For trials, check eligibility, location, burden, intervention, and contact details at the original registry. For device safety, check exact product names, models, lot numbers, software versions, and manufacturer instructions.
This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.